Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
NMR in Biomedicine|September 25, 2009
Intravoxel water diffusion heterogeneity imaging of human high-grade gliomasThomas C Kwee, Craig J Galbán, Christina Tsien, et al.
Nature Medicine|April 21, 2009
The parametric response map is an imaging biomarker for early cancer treatment outcomeCraig J Galbán, Thomas L Chenevert, Charles R Meyer, et al.
Nature Medicine|October 9, 2012
Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progressionCraig J Galbán, Meilan K Han, Jennifer L Boes, et al.
Translational Oncology|January 28, 2014
Impact of perfusion map analysis on early survival prediction accuracy in glioma patientsBenjamin Lemasson, Thomas L Chenevert, Theodore S Lawrence, et al.
Academic Radiology|December 3, 2014
Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS)Jennifer L Boes, Benjamin A Hoff, Maria Bule, et al.
Translational Oncology|July 21, 2020
UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancerYajing Liu, Sahezeel Awadia, Amy Delaney, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 29, 2004
The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapiesDaniel A Hamstra, Kuei C Lee, Joseph M Tychewicz, et al.
Cancer Research|May 3, 2006
Dynamic imaging of emerging resistance during cancer therapyKuei C Lee, Daniel E Hall, Benjamin A Hoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-DBradford A Moffat, Mark Chen, Muhammed S T Kariaapper, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2007
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculatureZhenhua Miao, Kathryn E Luker, Bretton C Summers, et al.
Pageof 16